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Dear Editor,
Anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) 
is an autoimmune inflammatory demyelinating disease of the central nervous system (CNS) 
that usually presents as optic neuritis and myelitis in adults.1 Cortical involvement in anti-
MOG antibody-positive encephalitis with seizure was recently suggested to be one of the 
clinical features in MOGAD.2 This distinct phenotype is referred to as FLAMES [unilateral 
cortical fluid-attenuated inversion recovery (FLAIR)-hyperintense lesions in anti-MOG-as-
sociated encephalitis with seizures], of which only a few cases have been reported.2 Here we 
present two cases of FLAMES in the Korean population. 
Case 1
A 44-year-old male developed mild fever and aphasia 1 day before admission. On admis-
sion he had motor aphasia on the language function test. A cerebrospinal fluid (CSF) exam-
ination revealed a normal pressure of 14 cm H2O, total nucleated cell count of 43/µL, pro-
tein level of 58.2 mg/dL, and glucose level of 59 mg/dL. Cortical swelling of the left parietal 
lobe was noted on FLAIR images, with corresponding cortical enhancement on gadolini-
um-enhanced T1-weighted images (Fig. 1A and B). No signal change was evident in diffu-
sion-weighted imaging (DWI) (Fig. 1C).
On day 2 the patient developed generalized tonic–clonic seizures accompanied by right-
sided head version. Intravenous phenytoin was administered to control the seizures. Despite 
the antiviral and antiepileptic treatments, the patient experienced further sensory aphasia. 
Immune-mediated encephalitis was suspected, and intravenous steroid pulse therapy was 
initiated. Motor aphasia improved significantly and there was no further seizure attack. The 
1-week follow-up brain magnetic resonance imaging (MRI) showed increased cortical swell-
ing in the left parietal lobe (Fig. 1D). However, his clinical symptoms markedly improved.
After discharge, the patient was found to be seropositive for anti-MOG antibodies after 
assessment by a live-cell fluorescence-activated cell-sorting assay using serum. Autoimmune 
encephalitis-associated autoantibodies including N-methyl-D-aspartate-receptor (NMDAR) 
antibodies were negative in both serum and CSF. Prednisolone and antiepileptic medications 
were gradually tapered without further clinical attacks occurring. Brain MRI performed 
5 months after symptom onset showed almost complete resolution of cortical swelling in 
the left parietal lobe (Fig. 1E). A follow-up neurologic examination demonstrated no focal 
neurologic deficit. Medications were discontinued and there were no additional attacks 
during a 12-month follow-up after the onset.
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Case 2
A 52-year-old female presented with acute-onset headache, 
nausea, and altered mental status. The initial FLAIR image 
showed cortical swelling on the left parietotemporal lobe, 
but the signal changes on DWI were less significant than 









Fig. 1. Brain MRI revealed a typical pattern of unilateral cortical FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures 
(FLAMES). A–E: Brain MRI of case 1. The FLAIR image obtained at admission showed mild cortical swelling on the left parietal lobe with a T2-weight-
ed hyperintensity (A, arrow). A gadolinium-enhanced T1-weighted image showed corresponding enhancement of the lesion but no definite lepto-
meningeal enhancement (B, arrow). No signal change was evident in DWI (C). The FLAIR-hyperintense lesion appeared more clearly in 1-week fol-
low-up brain MRI (D) and was almost resolved on the MRI image obtained 5 months after symptom onset (E). F, G, and H: Brain MRI of case 2. The 
initial FLAIR image showed cortical swelling of the left parietotemporal lobe (F, arrow) without significant change in DWI (G). The lesion had com-
pletely disappeared in 8-month follow-up MRI (H). DWI: diffusion-weighted imaging, FLAIR: fluid-attenuated inversion recovery, MOG: myelin oli-
godendrocyte glycoprotein, MRI: magnetic resonance imaging.
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of partial seizures occurred after admission, presenting as 
clonic movement of the right arm and right-sided head ver-
sion. The seizures were controlled with antiepileptic medica-
tions. Two weeks after discharge the patient developed mo-
tor aphasia and clonic seizures of her right face and arm. A 
CSF examination showed a normal pressure, total nucleat-
ed cell count of 12/µL, and protein level of 26.9 mg/dL. In-
travenous steroid pulse therapy improved her clinical 
symptoms without further seizure attacks. The patient was 
found to be seropositive for anti-MOG antibodies in a live-
cell fluorescence-activated cell-sorting assay using serum. 
Autoimmune encephalitis-related autoantibodies were not 
detected. The cortical swelling of the left parietotemporal 
lobe was not evident on 8-month follow-up MRI (Fig. 1H). 
Long-term immunotherapy with azathioprine was used to 
prevent relapses, and no further clinical attacks occurred 
during a 18-month follow-up. 
Cortical involvement is occasionally reported in patients 
with anti-MOG antibodies. However, a large proportion of 
the previous cases with anti-MOG antibody-positive enceph-
alitis having a cortical lesions also displayed additional lesions 
in the juxtacortical or deep white matter. Cases with FLAMES 
that solely have unilateral cortical hyperintensity on FLAIR 
images without involvement of adjacent juxtacortical white 
matter have rarely been reported.2 The association between 
anti-MOG antibody and cortical encephalitis with seizures 
has received considerable interest. Seizures and encephalitis 
are reported to be more common in MOGAD than in neu-
romyelitis optica spectrum disorder (NMOSD).3 Additional-
ly, a recent study suggested that cortical or juxtacortical le-
sions on brain MRI could help to distinguish MOGAD from 
NMOSD.4 Thus, the pattern of cortical involvement, includ-
ing FLAMES, can be a distinct phenotype of MOGAD. 
A previous study demonstrated that anti-MOG antibody 
is mainly associated with demyelination in the CNS.5 In ac-
quired inflammatory CNS disorders with anti-MOG antibody, 
the level of myelin basic protein (MBP), which is a marker of 
myelin breakdown, was elevated in CSF without any evidence 
of accompanying astrocyte damage. This finding suggests that 
anti-MOG antibody directly causes inflammatory demyelin-
ation. However, the role of anti-MOG antibody in cortical 
encephalitis has been questionable. The MBP level was not 
elevated in a recent study that assessed three patients with 
cortical encephalitis who were positive for anti-MOG anti-
body.6 Also, a direct relationship between cortical lesions and 
anti-MOG antibody was not observed in previous pathologic 
studies. Thus, anti-MOG antibody might not be directly patho-
genic in cases with anti-MOG antibody-positive cortical en-
cephalitis, and a coexisting autoimmune condition might be 
present. This is supported by several studies finding that anti-
MOG antibody can coexist with anti-NMDAR antibodies.7,8 
Further investigations are needed to find the link between 
anti-MOG antibody and cortical inflammation.
Early suspicion of FLAMES and testing for anti-MOG an-
tibodies are important for making appropriate therapeutic 
decisions. As in the present cases, a previous study also showed 
the good response and prognosis of patients with unilateral 
cortical FLAMES treated with corticosteroids.2 These obser-
vations indicate that serologic tests for anti-MOG antibod-
ies should be considered in patients presenting with seizure, 
encephalitis, and unilateral cortical involvement. 
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